The Geneva College of Longevity Science Semester Symposium, held in Guangzhou, China, brought together leading experts, researchers, and innovators from across the globe to discuss the latest breakthroughs in human longevity. The two-day event was a powerful reminder of how science, culture, and vision can converge to reshape the future of healthspan and aging.

One of the symposium’s highlights was a plenary lecture delivered by Prof. Milena Georgieva, Co-Founder and Chief Scientific Officer of Epix AI. Her presentation, focusing on the intersection of epigenetics and artificial intelligence, captivated the audience and sparked lively discussion on the future of longevity research.

Prof. Georgieva outlined how the integration of epigenetics and AI is unlocking new pathways to extend human life while reducing the risk of age-related diseases. She emphasized that personalization is central to this new era of longevity medicine.

“Genetics, epigenetics, and artificial intelligence together create the foundation for highly individualized preventive and therapeutic strategies,” Prof. Georgieva explained. “By tailoring interventions to each person’s unique biological profile, we can move beyond one-size-fits-all healthcare and make healthier, longer lives more attainable.”

Her lecture underscored the growing importance of personalized, data-driven approaches in medicine — an area where Epix AI is pioneering innovation with its Dynamic Health Score platform and proprietary biological age clocks.

The symposium in Guangzhou reinforced the critical role of interdisciplinary collaboration in the fight against aging, bringing together thought leaders to inspire progress in science, technology, and healthcare.

Epix AI’s participation reflects its mission to combine scientific rigor with innovation, helping shape a healthier future where longevity is not only about living longer but living better.